Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Smallpox
Pharma
Emergent finalizes deal for Chimerix's smallpox drug Tembexa
Emergent BioSolutions completed its acquisition of oral antiviral Tembexa from Chimerix, giving the U.S. another potential treatment for monkeypox.
Kevin Dunleavy
Sep 27, 2022 9:15am
FDA says overuse of Siga's Tpoxx could render it ineffective
Sep 15, 2022 10:54am
HHS earmarks $680M for smallpox drug, an Emergent buyout target
Aug 29, 2022 11:50am
U.S. orders another 2.5 million doses of Jynneos vaccine
Jul 18, 2022 10:49am
The US is ordering up more doses of the monkeypox shot Jynneos
Jul 5, 2022 9:00am
Amid monkeypox outbreak, Siga nabs $13M in smallpox drug orders
Jun 23, 2022 10:54am
